Riken Vitamin
4526.TFoods
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥96.3bn | ¥95.6bn | ¥91.5bn | ¥88.8bn | ¥79.2bn | ¥77.7bn |
| Operating income | ¥6.9bn | ¥8.7bn | ¥9.4bn | ¥7.2bn | ¥5.8bn | ¥1.4bn |
| Ordinary income | ¥7.7bn | ¥9.4bn | ¥10.3bn | ¥7.7bn | ¥6.2bn | ¥1.7bn |
| Net income (owners) | ¥7.0bn | ¥9.4bn | ¥8.8bn | ¥6.4bn | ¥21.6bn | −¥1.6bn |
| Total assets | ¥116.4bn | ¥113.0bn | ¥118.8bn | ¥105.2bn | ¥102.7bn | ¥106.5bn |
| Net assets / equity | ¥83.4bn | ¥79.2bn | ¥76.6bn | ¥71.4bn | ¥66.5bn | ¥46.7bn |
| Operating cash flow | ¥6.0bn | ¥7.9bn | ¥10.5bn | ¥7.8bn | ¥6.8bn | ¥7.6bn |
| EPS (basic) | ¥238.19 | ¥310.08 | ¥268.44 | ¥195.51 | ¥657.98 | ¥-49.36 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 4
| Period | Form | Figures |
|---|---|---|
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 49 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 73 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 47 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 199 figures · EDINET |
39 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| Domestic Chemical Business And Others | ¥8.7bn | ¥857m |
| Domestic Food Business | ¥66.4bn | ¥6.4bn |
| Overseas Business | ¥21.3bn | −¥436m |
| Adjustments & eliminations | — | ¥62m |
| Total | ¥96.3bn | ¥6.8bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.